Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression
暂无分享,去创建一个
Jie Han | Xiao Yang | Wei Zhang | Peng Li | Qiang Lv | Wei Zhang | Q. Lv | X. Yang | Wei Zhang | Jun Tao | Pengchao Li | J. Tao | Haiwei Yang | Jing-zi Wang | Haiwei Yang | Wenbo Yuan | Chengdi Yang | Jingzi Wang | Pengchao Li | Peng Li | Jie Han | Xiao Yang | Chengdi Yang | Wenbo Yuan | Qiang Lv | Q. Lv
[1] Peter Donnelly,et al. Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden , 2014, Nature Communications.
[2] X. Yang,et al. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1 , 2015, Tumor Biology.
[3] Jacques Ferlay,et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. , 2017, European urology.
[4] Yifeng Zhou,et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway , 2015, Oncotarget.
[5] Qiuyun Chen,et al. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression , 2016, Scientific Reports.
[6] Quanhong Sun,et al. Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway , 2016, BioMed research international.
[7] Junxia Chen,et al. Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma , 2016, Scientific Reports.
[8] M. Forouzanfar,et al. Global Burden of Urologic Cancers, 1990-2013. , 2017, European urology.
[9] Shuijun Zhang,et al. Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma , 2017, Oncotarget.
[10] S. Meltzer,et al. MicroRNA-224 Negatively Regulates p21 Expression During Late Neoplastic Progression in Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.
[11] T. Jin,et al. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression , 2014, Oncotarget.
[12] Hecheng Zhou,et al. CircRNA: functions and properties of a novel potential biomarker for cancer , 2017, Molecular Cancer.
[13] Huajie Cai,et al. cir-ITCH Plays an Inhibitory Role in Colorectal Cancer by Regulating the Wnt/β-Catenin Pathway , 2015, PloS one.
[14] Raoying Xie,et al. MiR‐17‐5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21 , 2016, Cancer medicine.
[15] J. Kjems,et al. Natural RNA circles function as efficient microRNA sponges , 2013, Nature.
[16] Haimin Li,et al. Circular RNA: A new star of noncoding RNAs. , 2015, Cancer letters.
[17] Lei Yu,et al. The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression , 2016, PloS one.
[18] Jun Shen,et al. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer , 2017, RNA biology.
[19] Hui-Kuan Lin,et al. Circular RNAs in cancer: novel insights into origins, properties, functions and implications. , 2015, American journal of cancer research.
[20] Q. Wan,et al. MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway , 2017, Scientific Reports.
[21] Dawood B. Dudekula,et al. CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs , 2016, RNA biology.
[22] Minmin Shi,et al. GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer. , 2016, Cancer letters.
[23] C. Cordon-Cardo,et al. Inactivation of p53 and Pten promotes invasive bladder cancer. , 2009, Genes & development.
[24] Sebastian D. Mackowiak,et al. Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.
[25] Yan Li,et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs , 2016, Nature Communications.
[26] Liangliang Yang,et al. Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7 , 2017, OncoTargets and therapy.
[27] F. Shen,et al. MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[28] E. Sacco,et al. Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer , 2012, Urologia Internationalis.
[29] G. Shan,et al. Targetable long non-coding RNAs in cancer treatments. , 2018, Cancer letters.
[30] Hui Zhou,et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..
[31] Rogerio Margis,et al. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. , 2016, Journal of biotechnology.
[32] S. Li,et al. Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma , 2015, BMC Cancer.
[33] Z. Ye,et al. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer. , 2015, International journal of clinical and experimental pathology.
[34] Aaron Ciechanover,et al. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. , 2008, Cancer cell.
[35] Shenglin Huang,et al. Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancer. , 2018, Cancer letters.